pubmed.ncbi.nlm.nih.gov/33567185/ Wilding JPH, Batterham RL, Davies M, Van Gaal LF, Kandler K, Konakli K, Lingvay I, McGowan BM, Oral TK, Rosenstock J, Wadden TA, Wharton S, Yokote K, Kushner RF
In studies involving patients with type 2 diabetes, semaglutide has been shown to significantly reduce HbA1c levels, which is a measure of long-term blood sugar control
This study tracked cellular ageing and found that those treated with semaglutide (compared with placebo) showed slower biological aging across inflammation, brain and heart ageing measures
Im running from them
GLP-1: Wirkungsweise des Darmhormons GLP-1 steht fr Glucagon-like Peptide-1 und wird in unserem Darm produziert
Role of the gut microbiota in type 2 diabetes and related diseases